⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for azenosertib

Every month we try and update this database with for azenosertib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Phase I/II Single-arm Trial of Azenosertib (ZN-c3) Combined With Carboplatin and Pembrolizumab in Patients With Metastatic Triple-negative Breast Cancer (ZAP-IT)NCT06351332
Breast Cancer
Breast Cancer F...
Triple Negative...
Hormone Recepto...
HER2-negative B...
Azenosertib
Carboplatin
Pembrolizumab
18 Years - Dana-Farber Cancer Institute
Targeted Pathway Inhibition in Patients With Pancreatic CancerNCT04005690
Locally Advance...
Metastatic Panc...
Stage II Pancre...
Stage III Pancr...
Stage IV Pancre...
Unresectable Pa...
Cobimetinib
Olaparib
Onvansertib
Azenosertib
18 Years - OHSU Knight Cancer Institute
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid TumorsNCT06364410
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Gast...
Metastatic Gast...
Metastatic Mali...
Unresectable Ga...
Unresectable Ga...
Unresectable Ma...
Azenosertib
Biopsy
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Magnetic Resona...
Multigated Acqu...
Trastuzumab Der...
18 Years - National Cancer Institute (NCI)
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid TumorsNCT06364410
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Gast...
Metastatic Gast...
Metastatic Mali...
Unresectable Ga...
Unresectable Ga...
Unresectable Ma...
Azenosertib
Biopsy
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Magnetic Resona...
Multigated Acqu...
Trastuzumab Der...
18 Years - National Cancer Institute (NCI)
Targeted Pathway Inhibition in Patients With Pancreatic CancerNCT04005690
Locally Advance...
Metastatic Panc...
Stage II Pancre...
Stage III Pancr...
Stage IV Pancre...
Unresectable Pa...
Cobimetinib
Olaparib
Onvansertib
Azenosertib
18 Years - OHSU Knight Cancer Institute
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: